Exponent Inc (EXPO) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows modest growth in revenue and net income, insider selling and lack of strong trading signals suggest caution. The technical indicators do not indicate a clear upward trend, and the stock appears fairly valued at its current price. Analysts have mixed views, with some upside potential, but the lack of recent news or significant catalysts makes this a hold rather than a buy.
The MACD is positive and expanding, suggesting a bullish trend, but RSI is in the neutral zone at 66.721, indicating no clear signal. Moving averages are converging, showing no strong directional trend. The stock is trading near its resistance level (R1: 74.233), which could limit immediate upside potential.

JPMorgan has an Overweight rating with a $100 price target, indicating 35% upside potential.
Insider selling has increased by 370.29% over the last month, which could indicate lack of confidence from management. Hedge funds are neutral, and there are no significant trading trends. Gross margin dropped to 0 in the latest quarter, which is a concerning financial metric.
In Q4 2025, revenue increased by 4.54% YoY to $129.38M, net income rose by 4.97% YoY to $24.76M, and EPS grew by 6.52% YoY to 0.49. However, gross margin dropped to 0, which is a significant negative.
Analysts have mixed ratings. UBS maintains a Neutral rating with a price target of $85, while JPMorgan initiated coverage with an Overweight rating and a $100 price target, citing potential for a strong rebound in fundamentals and valuation normalization.